Is a complete ETR/GXE research report available?

No complete published report is available for etr/GXE (ETR/GXE) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ETR/GXE (ETR/GXE)

Deutsche Börse Xetra: ETR/GXE · EUR

€24.5

+0.02 (+0.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ETR/GXE analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.6B
Revenue (ttm)	1B
Net income (ttm)	488.8M
EPS (ttm)	€7.42
P/E (trailing)	3.3x
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1B
Net income (ttm): 488.8M
EPS (ttm): €7.42
P/E (trailing): 3.3x
Market cap: 1.6B

All ETR/GXE indicators

Market & fundamental data

Available fields

158

Groups with data

Currency

EUR

Showing 158 of 158 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Belgium
Country code	DE
Employees	452
Employees Change	-146%
Employees Change Percent	-20.74
Enterprise value	EUR -1.3B
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-29
Market cap	EUR 1.6B
Price	EUR 24.52
Price currency	EUR
Rev Per Employee	2,309,185.84x
Sic	2836
Symbol	etr/GXE
Website	https://lakefrontbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	30.03%
FCF yield	-19.07%
P/B ratio	0.5x
P/E ratio	3.33x
P/S ratio	1.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	60.39%
EBITDA Margin	63.52%
Gross margin	68.53%
Gross Profit	EUR 715.3M
Net Income	EUR 488.8M
Pretax Margin	45.14%
Profit Margin	46.83%
Profit Per Employee	EUR 1.1M
ROA	10.65
Roa5y	0.27
ROCE	19.26
ROE	16.26
Roe5y	0.58
ROIC	241.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	262.17x
Revenue Growth Q	-91.36x
Revenue Growth3 Y	85.52x
Revenue Growth5 Y	16.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.28
Assets	EUR 3.4B
Cash	EUR 3B
Current Assets	EUR 3.1B
Current Liabilities	EUR 100.4M
Debt	EUR 6.4M
Debt EBITDA	EUR 0.01
Debt Equity	EUR 0
Debt FCF	EUR -0.02
Equity	EUR 3.3B
Interest Coverage	1,612
Liabilities	EUR 119.1M
Long Term Assets	EUR 311.7M
Long Term Liabilities	EUR 18.6M
Net Cash	EUR 3B
Net Cash By Market Cap	EUR 183
Net Cash Growth	-9.45%
Net Debt EBITDA	EUR -4.49
Net Debt Equity	EUR -0.91
Tangible Book Value	EUR 3.3B
Tangible Book Value Per Share	EUR 49.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	30.48
Inventory Turnover	11.69
Net Working Capital	EUR -20.3M
Quick ratio	30.23
Working Capital	EUR 3B
Working Capital Turnover	EUR 0.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	26.78
50-day SMA	24.82
50-day SMA vs 200-day SMA	50under200
All Time High	32.24
All Time High Change	-23.39%
All Time High Date	2025-10-03
All Time Low	22.84
All Time Low Change	8.14%
All Time Low Date	2026-05-20
ATR	0.33
Ch YTD	-12.04
High	24.52
High52	32.24
High52 Date	2025-10-03
High52ch	-23.95%
Low	24.52
Low52	22.84
Low52 Date	2026-05-20
Low52ch	7.36%
Ma50ch	-0.47%
Price vs 200-day SMA	-7.78%
RSI	40.28
RSI Monthly	0
RSI Weekly	43.78
Sharpe ratio	-0.45x
Sortino ratio	-0.47
Total Return	-0.03%
Tr YTD	-12.04
Tr1m	-1.12%
Tr1w	-3.97%
Tr3m	1.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 630.3M
Operating margin	60.39

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	40,940,711%
Net Borrowing	-2,772,000
Shares Insiders	0.01%
Shares Institutions	29.77%
Shares Qo Q	-0.07%
Shares Yo Y	0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -334.3M
Adjusted OCF	-325,598,000
Average Volume	29.45x
Bv Per Share	49.37
CAPEX	EUR -8.7M
Ch1m	-1.12
Ch1w	-3.97
Ch3m	1.31
Ch6m	-14.47
Change	0.08%
Change From Open	0
Close	24.5
Days Gap	0.08
Depreciation Amortization	32,673,500
Earnings Date	2026-08-10
EBIT	EUR 630.3M
EBITDA	EUR 663M
EPS	EUR 7.42
F Score	5
FCF	EUR -310.3M
FCF EV Yield	23.02x
Financing CF	-2,772,000
Fiscal Year End	December
Founded	1,999
Graham Number	90.10971
Graham Upside	267.5
Income Tax	EUR -16.7M
Investing CF	265,566,000
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Ma150	26.44
Ma150ch	-6.59%
Ma20	25.87
Ma20ch	-4.53%
Net CF	-41,262,000
Next Earnings Date	2026-08-10
Open	24.52
Ppne	76,950,000
Price Date	2026-07-28
Price EBITDA	EUR 2.46
Ptbv Ratio	0.5
Relative Volume	0.17x
Revenue	1,043,752,000x
SBC By Revenue	2.3x
Share Based Comp	23,999,000
Tax By Revenue	-1.6x
Tr6m	-14.47%
Volume	0
Z Score	10.97

ETR/GXE (ETR/GXE)

Coverage state: Market snapshot only — no published research

Generate the first ETR/GXE analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/GXE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/GXE indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ETR/GXE

Frequently asked questions